Skip to Content

Join the 'Vibativ' group to help and get support from people like you.

Vibativ News

Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)

Posted 10 May 2016 by Drugs.com

DUBLIN, IRELAND – (Marketwired) – 05/09/16 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for Vibativ (telavancin) to expand the product's label to include data describing the treatment of patients with concurrent Staphylococcus aureus (S. aureus) bacteremia in both of the antibiotic's currently approved indications in the United States. Vibativ is approved in the U.S. for the treatment of adult patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of S. aureus when alternative treatments are not suitable. In addition, Vibativ is approved in the U.S. for the treatment of adult patients with complicated skin & skin structure infections (cSSSI) caused ... Read more

Related support groups: Pneumonia, Skin and Structure Infection, Bacteremia, Vibativ, Telavancin

Health Tip: Understanding Antibiotics

Posted 9 Dec 2015 by Drugs.com

-- By taking an antibiotic as prescribed, you can get well faster and help prevent germs from becoming resistant to your medication. The U.S. Centers for Disease Control and Prevention offers these antibiotic guidelines: Never skip a dose of antibiotic. Always take it on schedule, as directed. Never stop taking an antibiotic early. Always take the entire prescription, unless your doctor tells you otherwise. Never save any antibiotic medication for a future illness. Never take an antibiotic that was prescribed for another person. Read more

Related support groups: Infections, Amoxicillin, Metronidazole, Doxycycline, Bacterial Infection, Cephalexin, Clindamycin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Flagyl, Keflex, Zithromax, Valtrex, Sulfamethoxazole, Trimethoprim, Acyclovir

Antibiotics May Not Help After 'Complicated' Appendectomy

Posted 2 Nov 2015 by Drugs.com

MONDAY, Nov. 2, 2015 – Antibiotics may not reduce the risk of infections in patients who undergo what's known as a "complicated" appendix removal, a new study finds. "The traditional teaching is that all patients with complicated appendicitis receive post-operative antibiotics to reduce the risk of wound infection or deep organ space infection," study lead author Dennis Kim, of the Los Angeles Biomedical Research Institute, explained in an institute news release. But is that advisory warranted? To find out, Kim's team tracked five-year outcomes for 410 patients. All of the patients had complicated appendectomies, meaning that their appendix was found to be perforated or gangrenous. About two-thirds of the patients received antibiotics after surgery. Those who received antibiotics had no fewer infections, Kim's team said, and they stayed in hospital an average of one day longer than ... Read more

Related support groups: Amoxicillin, Doxycycline, Cephalexin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Zithromax, Sulfamethoxazole, Erythromycin, Minocycline, Clarithromycin, Levofloxacin, Bactrim DS, Cefdinir, Vancomycin, Tetracycline, Avelox

Medicines Are Biggest Culprit in Fatal Allergic Reactions: Study

Posted 10 Oct 2014 by Drugs.com

THURSDAY, Oct. 9, 2014 – Although food allergies have garnered a lot of attention lately, a new study reports that medications are actually the biggest cause of sudden deaths related to allergy. Over a little more than a decade, nearly 60 percent of the allergy-related deaths were caused by medications, while less than 7 percent were caused by food allergies, the study found. "Medications can be dangerous," said study researcher Dr. Elina Jerschow, director of the Drug Allergy Center at Montefiore Medical Center and assistant professor of medicine at Albert Einstein College of Medicine, in New York City. While research from other countries has reported medications as a major culprit in anaphylaxis-related deaths, Jerschow said, the problem has been less defined in the United States. One reason is that there is no national registry for anaphylaxis deaths, she said. The study was ... Read more

Related support groups: Provera, Depo-Provera, Amoxicillin, Metronidazole, Doxycycline, Cephalexin, Clindamycin, Penicillin, Methotrexate, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Accutane, Augmentin, Levaquin, Lupron, Flagyl, Keflex, Zithromax

Hospitals' High Antibiotic Use May Boost Germs' Resistance: Study

Posted 7 Oct 2014 by Drugs.com

TUESDAY, Oct. 7, 2014 – About half of all U.S. hospital patients receive antibiotics, and these drugs are commonly the ones more likely to promote the growth of antibiotic-resistant bacteria, a new study found. "This is where the bad bugs spread, in the hospitals, because so many people are receiving antibiotics, and one of the only things that can spread are the antibiotic-resistant bugs," said Dr. Eli Perencevich, an infectious disease epidemiologist at the University of Iowa Carver College of Medicine. "We have to figure out better ways to reduce excess antibiotic use, and one way to do that is to get better at making diagnoses," he added. The study identified how many of more than 11,000 patients received antibiotics on a given day at one of 183 hospitals throughout the United States in 2011. The researchers found that 50 percent of these patients got at least one antibiotic, and ... Read more

Related support groups: Bacterial Infection, Cephalexin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Zithromax, Sulfamethoxazole, Erythromycin, Clarithromycin, Methicillin-Resistant Staphylococcus Aureus Infection, Levofloxacin, Bactrim DS, Cefdinir, Vancomycin, Avelox, Biaxin, Sulfamethoxazole/Trimethoprim

Vibativ Approved for Certain Bacterial Pneumonia

Posted 24 Jun 2013 by Drugs.com

MONDAY, June 24 – The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable. Pneumonia, a lung infection, can be caused by different bacteria and viruses. S. aureus infection often affects people in hospitals, notably those on ventilators. Such infections can be serious, since people on a ventilator often have a weakened immune system and are unable to fight an infection, the FDA said in a news release. Vibativ's safety and effectiveness were evaluated clinically among 1,532 people. The studies found the drug was about as effective in treating S. aureus pneumonia as another approved antibiotic, vancomycin. However, the studies found that more people treated with Vibativ died if they also had kidney problems, compared to kidney patients who took ... Read more

Related support groups: Pneumonia, Vibativ, Telavancin

FDA Approves Vibativ for Hospitalized Patients with Bacterial Pneumonia

Posted 23 Jun 2013 by Drugs.com

June 21, 2013 – The U.S. Food and Drug Administration today expanded the approved use of the antibiotic Vibativ (telavancin) to treat patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by Staphylococcus aureus. Vibativ should be used for the treatment of HABP/VABP only when alternative treatments are not suitable. Bacterial pneumonia is a lung infection that can be caused by many different types of bacteria. Vibativ is approved only to treat S. aureus, not other bacteria that cause pneumonia. HABP/VABP, also known as nosocomial pneumonia, is a particularly serious lung infection because patients in the hospital and especially those on ventilators are often already very sick and usually cannot fight the infection. “Today’s approval demonstrates the FDA’s commitment to making available new therapeutic options to treat serious diseases like ... Read more

Related support groups: Pneumonia, Vibativ, Telavancin

Smarten Up About Antibiotics, CDC Urges

Posted 18 Nov 2010 by Drugs.com

THURSDAY, Nov. 18 – Knowing when to take antibiotics – and when not to – can help fight the rise of deadly "superbugs," say experts at the U.S. Centers for Disease Control and Prevention. About half of antibiotics prescribed are unnecessary or inappropriate, the agency says, and overuse has helped create bacteria that don't respond, or respond less effectively, to the drugs used to fight them. "Antibiotics are a shared resource that has become a scarce resource," said Dr. Lauri Hicks, a medical epidemiologist at the CDC. She's also medical director a of new program, Get Smart: Know When Antibiotics Work, that had its launch this week. "Everyone has a role to play in preventing the spread of antibiotic resistance," Hicks said. The stakes are high, said Dr. Arjun Srinivasan, CDC's associate director for health care-associated infection prevention programs. Almost every type of bacteria ... Read more

Related support groups: Infections, Amoxicillin, Metronidazole, Doxycycline, Cephalexin, Clindamycin, Penicillin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Fluconazole, Augmentin, Levaquin, Flagyl, Keflex, Zithromax, Sulfamethoxazole, Trimethoprim, Diflucan

A Radical Plan To Save Antibiotics

Posted 7 Sep 2010 by Drugs.com

From Guardian Web (September 7, 2010) What are we to do about the diminishing power of antibiotics - once the miracle drugs that looked set to end infectious diseases? We know the problem is becoming very serious - here is a piece I wrote about the alarming prospects for a future without antibiotics. But we don’t hear much in the way of imaginative answers. So it’s refreshing to read a paper out this morning from Aaron Kesselheim, from Brigham and Women’s Hospital and Harvard Medical School in Boston, and Kevin Outterson, a professor at Boston University Law School. Their analysis, published in the journal Health Affairs, says the usual idea, to give pharmaceutical companies financial incentives to invent and manufacture more antibiotics, won’t work. One of the reasons we are in this parlous state of affairs, they say, is that drug companies in the past have tried too hard to sell more ... Read more

Related support groups: Infections, Amoxicillin, Metronidazole, Doxycycline, Cephalexin, Penicillin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Flagyl, Keflex, Zithromax, Sulfamethoxazole, Trimethoprim, Nitrofurantoin, Erythromycin, Minocycline

Ask a Question

Further Information

Related Condition Support Groups

Skin and Structure Infection, Pneumonia, Nosocomial Pneumonia

Vibativ Patient Information at Drugs.com